Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity

被引：11

作者：

Benucci, Maurizio ^{[1
]}

Grossi, Valentina ^{[2
]}

Manfredi, Mariangela ^{[2
]}

Damiani, Arianna ^{[1
]}

Infantino, Maria ^{[2
]}

Moscato, Paolo ^{[3
]}

Cinquanta, Luigi ^{[5
]}

Gremese, Elisa ^{[4
,6
]}

Tolusso, Barbara ^{[4
]}

Petricca, Luca ^{[4
]}

Fedele, Anna Laura ^{[4
]}

Alivernini, Stefano ^{[4
,6
]}

Atzeni, Fabiola ^{[7
]}

Minisola, Giovanni ^{[8
]}

Verna, Roberto ^{[9
,10
]}

机构：

[1] S Giovanni di Dio Hosp, Rheumatol Unit, Florence, Italy

[2] S Giovanni di Dio Hosp, Immunol & Allergol Lab Unit, Florence, Italy

[3] Univ Hosp San Giovanni di Dio & Ruggi dAragona, Dept Med, Salerno, Italy

[4] IRCCS, Fdn Policlin Univ A Gemelli, Div Rheumatol, Rome, Italy

[5] SDN SPA Synlab Lab, Salerno, Italy

[6] Univ Cattolica Sacro Cuore, Div Rheumatol, Rome, Italy

[7] Univ Messina, Rheumatol Unit, Messina, Italy

[8] Italian Soc Rheumatol, Milan, Italy

[9] World Assoc Soc Pathol & Lab Med, Milan, Italy

[10] Sapienza Univ Rome, Dept Expt Med, Viale Regina Elena 324, I-00161 Rome, Italy

来源：

ANNALS OF LABORATORY MEDICINE | 2020年 / 40卷 / 02期

关键词：

Anti-tumor necrosis factor (TNF) drugs; Antibodies; Anti-drug antibodies; Bio-logical drugs; LONG-TERM TREATMENT; CHRONIC INFLAMMATORY DISEASES; ANTI-INFLIXIMAB ANTIBODIES; POINT-OF-CARE; ARTHRITIS PATIENTS; ANKYLOSING-SPONDYLITIS; DOUBLE-BLIND; ADALIMUMAB ANTIBODIES; INNOVATOR INFLIXIMAB; TREATMENT FAILURE;

D O I：

10.3343/alm.2020.40.2.101

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Biological drugs, such as proteins and immunogens, are increasingly used to treat various diseases, including tumors and autoimmune diseases, and biological molecules have almost completely replaced synthetic drugs in rheumatology. Although biological treatments such as anti-tumor necrosis factor (TNF) drugs seem to be quite safe, they cause some undesirable effects, such as the onset of infections due to weakening of the immune system. Given the biological nature of these drugs, they might be recognized as extraneous; this would induce an immune reaction that neutralizes their effectiveness or lead to more serious consequences. Laboratories play a pivotal role in appropriate therapeutic management. The aim of this review was to underline the production of anti-drug antibodies during treatment with biological drugs and highlight the role of laboratories in ensuring appropriate use of these drugs.

引用

页码：101 / 113

页数：13

共 93 条

[61] State-of-the-art immunogenicity evaluation in phase 3 confirmatory study (EGALITY) with etanercept biosimilar GP2015 [J].

Poetzl, J. ;

Arlt, I. ;

von Richter, O. ;

Woehling, H. ;

Afonso, M. ;

Schaffar, G. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (04) :E130-E132

[62] Multi-center Performance Evaluations of Tacrolimus and Cyclosporine Electrochemiluminescence Immunoassays in the Asia-Pacific Region [J].

Qin, Xuzhen ;

Rui, Jianzhong ;

Xia, Yong ;

Mu, Hong ;

Song, Sang Hoon ;

Aziddin, Raja Elina Raja ;

Miles, Gabrielle ;

Sun, Yuli ;

Chun, Sail .

ANNALS OF LABORATORY MEDICINE, 2018, 38 (02) :85-+

[63] Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis [J].

Quistrebert, Jocelyn ;

Hassler, Signe ;

Bachelet, Delphine ;

Mbogning, Cyprien ;

Musters, Anne ;

Tak, Paul Peter ;

Wijbrandts, Carla Ann ;

Herenius, Marieke ;

Bergstra, Sytske Anne ;

Akdemir, Gulsah ;

Johannesson, Martina ;

Combe, Bernard ;

Fautrel, Bruno ;

Chollet-Martin, Sylvie ;

Gleizes, Aude ;

Donnellan, Naoimh ;

Deisenhammer, Florian ;

Davidson, Julie ;

Hincelin-Mery, Agnes ;

Donnes, Pierre ;

Fogdell-Hahn, Anna ;

De Vries, Niek ;

Huizinga, Tom ;

Abugessaisa, Imad ;

Saevarsdottir, Saedis ;

Hacein-Bey-Abina, Salima ;

Pallardy, Marc ;

Broet, Philippe ;

Mariette, Xavier .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 48 (06) :967-975

[64] Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis [J].

Radstake, T. R. D. J. ;

Svenson, M. ;

Eijsbouts, A. M. ;

van den Hoogen, F. H. J. ;

Enevold, C. ;

van Riel, P. L. C. M. ;

Bendtzen, K. .

ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (11) :1739-1745

[65] Immunogenicity of Monoclonal Antibodies Against Tumor Necrosis Factor Used in Chronic Immune-Mediated Inflammatory Conditions Systematic Review and Meta-analysis [J].

Ramon Maneiro, Jose ;

Salgado, Eva ;

Jesus Gomez-Reino, Juan .

JAMA INTERNAL MEDICINE, 2013, 173 (15) :1416-1428

[66] Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents [J].

Reinisch, Walter ;

Jahnsen, Jorgen ;

Schreiber, Stefan ;

Danese, Silvio ;

Panes, Julian ;

Balsa, Alejandro ;

Park, Won ;

Kim, JiSoo ;

Lee, Jee Un ;

Yoo, Dae Hyun .

BIODRUGS, 2017, 31 (03) :223-237

[67] Rapid affinity measurement of protein-protein interactions in a microfluidic platform [J].

Salimi-Moosavi, Hossein ;

Rathanaswami, Palaniswami ;

Rajendran, Surendran ;

Toupikov, Mike ;

Hill, John .

ANALYTICAL BIOCHEMISTRY, 2012, 426 (02) :134-141

[68] Immunogenicity of biologic agents in rheumatoid arthritis patients: lessons for clinical practice [J].

Schaeverbeke, Thierry ;

Truchetet, Marie-Elise ;

Kostine, Marie ;

Barnetche, Thomas ;

Bannwarth, Bernard ;

Richez, Christophe .

RHEUMATOLOGY, 2016, 55 (02) :210-220

[69] Therapeutic drug monitoring (TDM) as a tool in the switch from infliximab innovator to biosimilar in rheumatic patients: results of a 12-month observational prospective cohort study [J].

Schmitz, E. M. H. ;

Benoy-De Keuster, S. ;

Meier, A. J. L. ;

Scharnhorst, V. ;

Traksel, R. A. M. ;

Broeren, M. A. C. ;

Derijks, L. J. J. .

CLINICAL RHEUMATOLOGY, 2017, 36 (09) :2129-2134

[70] Therapeutic drug monitoring of infliximab: performance evaluation of three commercial ELISA kits [J].

Schmitz, Ellen M. H. ;

van de Kerkhof, Daan ;

Hamann, Dorte ;

van Dongen, Joost L. J. ;

Kuijper, Philip H. M. ;

Brunsveld, Luc ;

Scharnhorst, Volkher ;

Broeren, Maarten A. C. .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (07) :1211-1219

← 1 2 3 4 5 6 7 8 9 10 →